Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 25 contracts
Samples: Collaboration and License Agreement (Aravive, Inc.), License and Collaboration Agreement (Visterra, Inc.), Collaboration and License Agreement (Inovio Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1any other provision of this Agreement, a each Party may disclose Confidential Information of the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 23 contracts
Samples: Licensing Agreement (Gilead Sciences Inc), Commercialization Agreement (Pozen Inc /Nc), License and Collaboration Agreement (Nuvelo Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1provisions of Sections 9.1.1, a 9.2, or 9.3, each Party may disclose Confidential Information belonging to the other Party’s Confidential Information and the terms of this Agreement Party to the extentextent such disclosure is reasonably necessary to:
Appears in 10 contracts
Samples: Collaboration, License and Option Agreement (Acceleron Pharma Inc), License and Option Agreement (Acceleron Pharma Inc), License and Option Agreement (Acceleron Pharma Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.111.1 above, a Party may shall be entitled to disclose the other Party’s Confidential Information and of the terms of this Agreement other Party hereto to the extentextent that such disclosure is:
Appears in 7 contracts
Samples: X” Exclusive License Agreement (SCOLR Pharma, Inc.), Exclusive License Agreement (RedHill Biopharma Ltd.), Exclusive License Agreement (RedHill Biopharma Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 7 contracts
Samples: License and Collaboration Agreement (Graphite Bio, Inc.), License and Option Agreement (Pfenex Inc.), License and Collaboration Agreement (Oyster Point Pharma, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.17.1, a Party may disclose Confidential Information of the other Party’s Confidential Information and the terms of this Agreement Party to the extentextent such disclosure is reasonably necessary in the following instances:
Appears in 6 contracts
Samples: Collaboration and License Agreement (Xencor Inc), Collaboration and License Agreement (MorphoSys AG), Collaboration and License Agreement (Xencor Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in foregoing provisions of Section 12.1, a each Party may disclose Confidential Information belonging to the other Party’s Confidential Information and the terms of this Agreement Party to the extentextent such disclosure is reasonably necessary to:
Appears in 6 contracts
Samples: Collaboration, Option and License Agreement (Vertex Pharmaceuticals Inc / Ma), Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission (Applied Genetic Technologies Corp), Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission (Applied Genetic Technologies Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.113.1 above, a Party may shall be entitled to disclose the other Party’s Confidential Information and of the terms of this Agreement other Party hereto to the extentextent that such disclosure is:
Appears in 6 contracts
Samples: Development and Commercialization Agreement (RedHill Biopharma Ltd.), Development and Commercialisation Agreement (Pacific Therapeutics Ltd.), Development and Commercialization Agreement (IntelGenx Technologies Corp.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 5 contracts
Samples: License, Development and Commercialization Agreement (Impax Laboratories Inc), License and Collaboration Agreement (Cytokinetics Inc), Supply Agreement (Spectrum Pharmaceuticals Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.18.1 or 8.2, a either Party may disclose Confidential Information of the other Party’s Confidential Information and , or make such a disclosure of the existence of and/or terms of this Agreement to the extentAgreement:
Appears in 5 contracts
Samples: Collaboration and License Agreement (Ultragenyx Pharmaceutical Inc.), Collaboration and License Agreement (Dimension Therapeutics, Inc.), Collaboration and License Agreement (Dimension Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 5 contracts
Samples: Assignment, License, and Collaboration Agreement (Journey Medical Corp), License, Development and Commercialization Agreement (Spectrum Pharmaceuticals Inc), License, Development and Commercialization Agreement (Allos Therapeutics Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.114.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 5 contracts
Samples: Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc), Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc), Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.18.1.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 4 contracts
Samples: Co Promotion Agreement (Eagle Pharmaceuticals, Inc.), Co Promotion Agreement (Tyme Technologies, Inc.), Co Promotion Agreement (G1 Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.18.1.1 and Section 8.2, a each Party may disclose Confidential Information belonging to the other Party’s Confidential Information and the terms of this Agreement Party to the extentextent such disclosure is reasonably necessary to:
Appears in 4 contracts
Samples: License and Collaboration Agreement (Genocea Biosciences, Inc.), License and Collaboration Agreement (Genocea Biosciences, Inc.), License and Collaboration Agreement (Genocea Biosciences, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.18.1, a the Receiving Party may disclose the other Disclosing Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 4 contracts
Samples: Collaboration and License Agreement (Relief Therapeutics Holding SA), Trial Agreement (Tracon Pharmaceuticals, Inc.), Exclusive License Agreement (Acer Therapeutics Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.17.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 4 contracts
Samples: Option and License Agreement (Yumanity Therapeutics, Inc.), Option and License Agreement (Yumanity Therapeutics, Inc.), Cd38 Product Collaboration Agreement (I-Mab)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 4 contracts
Samples: Option and License Agreement (Exicure, Inc.), License and Development Agreement (Brickell Biotech, Inc.), Exclusive License Agreement (Brickell Biotech, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.112.2, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 3 contracts
Samples: License and Commercial Supply Agreement (Intellipharmaceutics International Inc.), License and Commercial Supply Agreement (Intellipharmaceutics International Inc.), License and Commercial Supply Agreement (Intellipharmaceutics International Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in foregoing provisions of Section 12.114.1, a each Party may disclose Confidential Information belonging to the other Party’s Confidential Information and the terms of this Agreement Party to the extentextent such disclosure is reasonably necessary to:
Appears in 3 contracts
Samples: Research Collaboration Agreement (Nkarta, Inc.), Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission (Applied Genetic Technologies Corp), Collaboration and License Agreement (Applied Genetic Technologies Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.18.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 3 contracts
Samples: License Agreement (Genelux Corp), License Agreement (Genelux Corp), License Agreement (Genelux Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a each Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent such disclosure is reasonably necessary to:
Appears in 3 contracts
Samples: Sublicense Agreement (Entrada Therapeutics, Inc.), Sublicense Agreement (Entrada Therapeutics, Inc.), Sublicense Agreement (Entrada Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.18.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 3 contracts
Samples: License Agreement (RayzeBio, Inc.), License Agreement (RayzeBio, Inc.), License Agreement (RayzeBio, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent such disclosure is reasonable necessary in the following instances:
Appears in 2 contracts
Samples: Exclusive License Agreement (Intrexon Corp), Exclusive License Agreement (Ziopharm Oncology Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentAgreement:
Appears in 2 contracts
Samples: Development and License Agreement (Concert Pharmaceuticals, Inc.), Development and License Agreement (Concert Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1any other provision of this Agreement or applicable Ancillary Agreement, a each Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentanother Party:
Appears in 2 contracts
Samples: Master Agreement (Gilead Sciences Inc), Master Agreement (Gilead Sciences Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement (which terms shall be the Confidential Information of both Parties) to the extent:
Appears in 2 contracts
Samples: Technology License Agreement (Oramed Pharmaceuticals Inc.), License Agreement (Cypress Bioscience Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.113.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 2 contracts
Samples: Discovery Alliance Agreement (Molecular Partners Ag), First Collaboration and License Agreement (Arrowhead Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.14.1, a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 2 contracts
Samples: Non Exclusive License Agreement (SWK Holdings Corp), Non Exclusive License Agreement (Cara Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.17.1, a Receiving Party may disclose the other Disclosing Party’s Confidential Information and the terms of this Agreement solely to the extent:
Appears in 2 contracts
Samples: License Agreement (Poseida Therapeutics, Inc.), License Agreement (Poseida Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1any other provision of this Agreement, a each Party may disclose Confidential Information of the other Party’s Confidential Information and the terms of this Agreement to the extent:: * CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED WITH THE COMMISSION
Appears in 2 contracts
Samples: License Agreement (Cubist Pharmaceuticals Inc), License Agreement (Cubist Pharmaceuticals Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.114.1 above, a Party may shall be entitled to disclose the other Party’s Confidential Information and the terms of this Agreement another Party hereto to the extentextent that such disclosure is:
Appears in 2 contracts
Samples: Promotion Agreement (Jaguar Health, Inc.), Exclusive Commercialization Agreement (RedHill Biopharma Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1Section10.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 2 contracts
Samples: Collaboration and Option Agreement (Aridis Pharmaceuticals, Inc.), Collaboration and Option Agreement (Aridis Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a each Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent such disclosure is reasonably necessary to:
Appears in 2 contracts
Samples: Master Collaboration Agreement (Kymera Therapeutics, Inc.), Master Collaboration Agreement (Molecular Templates, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section Article 12.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 2 contracts
Samples: License, Collaboration and Distribution Agreement (Midatech Pharma PLC), License, Collaboration and Distribution Agreement (Midatech Pharma PLC)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.16.1 and Section 6.3, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 2 contracts
Samples: License Agreement (Arog Pharmaceuticals, Inc.), License Agreement (Arog Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a the Party may disclose the other Party’s Confidential Information and received from the terms of this Agreement other Party to the extent:
Appears in 2 contracts
Samples: License Agreement (Celladon Corp), License Agreement (Celladon Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a the Receiving Party may disclose the other Disclosing Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Exclusive License Agreement (Skye Bioscience, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.15.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License, Commercialization and Option Agreement (Acura Pharmaceuticals, Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.17.2, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Assignment and Novation Agreement (Kythera Biopharmaceuticals Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.19.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent such disclosure is reasonable necessary in the following instances:
Appears in 1 contract
Samples: Exclusive License Agreement (Alaunos Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a either Party or its respective Affiliates may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party may disclose the other Party’s Confidential Information and or the terms of this Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in foregoing provisions of Section 12.18.1, a each Party may disclose Confidential Information belonging to the other Party (or such Party’s Confidential Information and the terms of this Agreement Affiliate) to the extentextent such disclosure is reasonably necessary to:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1Article 10.1, a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Co Development and Manufacturing Agreement (Prometheus Biosciences, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a Party may disclose the other Party’s 's Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License and Collaboration Agreement (Theravance Biopharma, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.19.1, a the Receiving Party may disclose the other Disclosing Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Collaborative Development and Commercialization Agreement (Tracon Pharmaceuticals, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.18.1, a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Distribution Agreement (Acelrx Pharmaceuticals Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.118.1, a Party party may disclose the other Partyparty’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Exclusive License Agreement (Amplitude Healthcare Acquisition Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a each Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (CollPlant Holdings Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party may disclose the other Party’s 's Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.115.1 above, a Party may shall be entitled to disclose the other Party’s Confidential Information and of the terms of this Agreement other Party hereto to the extentextent that such disclosure is:
Appears in 1 contract
Samples: Exclusive License Agreement (RedHill Biopharma Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.115.1, a Party may use and disclose Confidential Information belonging to the other Party’s Confidential Information and the terms of this Agreement to the extentParty as follows:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement (which terms shall be the Confidential Information of both Parties) to the extent:: [***] Omitted pursuant to a confidential treatment request. The confidential portion has been filed separately with the SEC.
Appears in 1 contract
Samples: License Agreement (BioLineRx Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent such disclosure is reasonably necessary in the following instances:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.19.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. (a) Notwithstanding the obligations set forth in Section 12.111.01, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License, Distribution and Supply Agreement (PolyPid Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.17.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement (which terms shall be the Confidential Information of both Parties) to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section Article 12.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement or the Exclusive Trademark License to the extent:
Appears in 1 contract
Samples: License, Collaboration and Supply Agreement (Capstar Special Purpose Acquisition Corp.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.16.1 and Section 6.3, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License Agreement (Corbus Pharmaceuticals Holdings, Inc.)
Authorized Disclosure. 11.2.1. Notwithstanding Section 11.1 (Confidentiality), the obligations set forth in Section 12.1, a Receiving Party may disclose the other Disclosing Party’s Confidential Information and the existence and terms of this Agreement to the extentextent such disclosure is reasonably necessary to:
Appears in 1 contract
Samples: Collaboration and License Agreement (Fulcrum Therapeutics, Inc.)
Authorized Disclosure. (a) Notwithstanding the obligations set forth in Section 12.19.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.1, a Party may disclose the other Party’s Confidential Information and including the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License Agreement (Tranzyme Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party or its Affiliate may disclose the other Party’s 's Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Allos Therapeutics Inc)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.19.1.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Promotion Agreement (Liquidia Corp)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.110.1, a Party may disclose the other Party’s Confidential Information and Information, including the terms of this Agreement Agreement, to the extent:
Appears in 1 contract
Samples: License and Collaboration Agreement (ADC Therapeutics SA)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.111.1, a Party may disclose the other Party’s Confidential Information, the terms of this Agreement (which terms shall be the Confidential Information of both Parties) and the terms existence of this Agreement to the extent:
Appears in 1 contract
Samples: Investment and Collaboration Agreement (BioLineRx Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.16.1, a Party may disclose the other Party’s Confidential Information and or the terms of this License Agreement to the extent:
Appears in 1 contract
Authorized Disclosure. Notwithstanding the obligations set forth in provisions of Section 12.115.1 above, a Party may shall be entitled to disclose the other Party’s Confidential Information and the terms of this Agreement another Party hereto to the extentextent that such disclosure is:
Appears in 1 contract
Samples: Exclusive Commercialization Agreement (RedHill Biopharma Ltd.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.19.1 (Confidentiality), a Party or its Affiliate may disclose the other Party’s Confidential Information and the terms of this Agreement to the extent:
Appears in 1 contract
Samples: Intellectual Property Assignment and License Agreement (MiNK Therapeutics, Inc.)
Authorized Disclosure. Notwithstanding the obligations set forth in Section 12.113.1, a Party may disclose the other Party’s Confidential Information and the terms of this Agreement to the extentextent necessary for:
Appears in 1 contract
Samples: Exclusive Collaboration and License Agreement (Sunesis Pharmaceuticals Inc)
